1 / 5

Osteoscoop - Issue N°289 – May 2013

Nuclear Fibroblast Growth Factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23/FGFR/MAPK in vitro. Osteoscoop - Issue N°289 – May 2013. Bone m esenchymal s tem c ell. FGF2. Decreased bone mineralization. HMW. FGF23. LMW. Bone m esenchymal stem cell.

sanam
Télécharger la présentation

Osteoscoop - Issue N°289 – May 2013

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nuclear Fibroblast Growth Factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23/FGFR/MAPK in vitro Osteoscoop - Issue N°289 – May 2013

  2. Bone mesenchymalstem cell FGF2 Decreased bone mineralization HMW FGF23 LMW

  3. Bone mesenchymal stem cell FGF2 Decreased bone mineralization HMW FGF23 LMW HMW HMW FGFR1 FGFR1 Fgf23 Nucleus

  4. Bone mesenchymal stem cell FGF2 Decreased bone mineralization HMW FGF23 LMW MAPK FGFR HMW HMW FGFR1 FGFR1 + FGF23 FGF23 Fgf23 Nucleus

  5. Bone mesenchymal stem cell FGF2 Decreased bone mineralization HMW FGF23 LMW MAPK FGFR HMW HMW FGFR1 FGFR1 + FGF23 FGF23 - OCN Fgf23 Nucleus

More Related